Bone and Joint Infection Clinical Trial
Official title:
Septic Management and Outcome of Open Fracture : a 7 Years Retrospective Cohort Study
NCT number | NCT04418882 |
Other study ID # | 20-204 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | May 15, 2020 |
Est. completion date | December 1, 2021 |
Verified date | January 2022 |
Source | Hospices Civils de Lyon |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The aim is the study of the management and outcome of the open fractures. Some open fractures will become pseudarthrosis. Thoses pseudarthrosis may be septic or not. The management and evolution of all the open fractures will be described in order to identify the presence or not of a sepsis and then a development of a pseudarthrosis (septic or non septic).
Status | Completed |
Enrollment | 400 |
Est. completion date | December 1, 2021 |
Est. primary completion date | July 1, 2020 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - all patients with open fractures Exclusion Criteria: - |
Country | Name | City | State |
---|---|---|---|
France | Hospices Civils de Lyon | Lyon |
Lead Sponsor | Collaborator |
---|---|
Hospices Civils de Lyon |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | description of non septic open fracture | description of surgical management | 24 months | |
Primary | description of patients with non septic open fracture | description of patients : average age, medical background | 1 month | |
Primary | description of septic open fracture : bacteriology | type of bacteria involved in the infection | 24 months | |
Primary | description of septic open fracture : evolution | description of symptoms | 24 months | |
Primary | description of septic open fracture : management | description of surgical and medical management | 24 months | |
Primary | description of septic open fracture : patients | description of patients : average age, medical background | 24 months | |
Primary | description of pseudarthrosis: symptoms | description of symptoms | 24 months | |
Primary | description of pseudarthrosis : management | description of management: surgical and medical management | 24 months | |
Primary | description of septic pseudarthrosis : patients | description of patients : average age, medical background | 24 months | |
Primary | description of septic pseudarthrosis : bacteriology | type of bacteria involved in the infection | 24 months | |
Primary | treatment failure | rate and description of treatment failure.Treatment failure is defined by local clinical and/or microbiological relapse; and/or need for additional surgery; death of septic origin | 24 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05421312 -
Periarticular Penetration of Cefazolin and Clindamycin in Second Stage Revision Arthroplasty of the Hip
|
Phase 4 | |
Active, not recruiting |
NCT04563325 -
Oral-only Antibiotics for Bone and Joint Infections in Children
|
Phase 4 | |
Completed |
NCT03627000 -
Microbiological Epidemiology in Patients Experiencing Microbiological or Clinical Failure Following Reimplantation After a 2-stage Exchange Strategy for Hip or Knee Prosthetic Joint Infection
|
||
Completed |
NCT03311113 -
Adherence to Oral Antibiotics In Patients With Osteoarticular Infections
|
||
Recruiting |
NCT05753215 -
Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection
|
Phase 2 | |
Completed |
NCT03209921 -
Pharmacokinetic Variability of Daptomycin During Prolonged Therapy for Bone and Joint Infections
|
N/A | |
Completed |
NCT05248490 -
Impact of Pharmaceutical Interviews Regarding the Management of Adverse Effects Related to the Antibiotic Therapy Used to Treat Osteoarticular Infections During Return Home
|
N/A | |
Completed |
NCT03624855 -
Implant-Associated P. Aeruginosa Bone And Joint Infections : Experience In A Regional Reference Center In France
|
||
Recruiting |
NCT04496024 -
Ofloxacin Concentration-toxicity Relationship in the Elderly
|
N/A | |
Recruiting |
NCT04933344 -
Pharmacokinetics and Toxicodynamics of Daptomycin in Bone and Joint Infections
|
||
Recruiting |
NCT04538053 -
BonE and Joint Infections - Simplifying Treatment in Children Trial
|
Phase 4 | |
Completed |
NCT04373278 -
Infection After Free Fibula Flap Reconstruction of the Mandible: a Retrospective Cohort Study
|
||
Completed |
NCT03209934 -
Daptomycin > 6 mg/kg/Day as Salvage Therapy in Patients With Complex Bone and Joint Infection: Cohort Study in a Regionalreference Center
|
N/A | |
Recruiting |
NCT02817711 -
Lyon BJI Cohort Study
|
N/A | |
Recruiting |
NCT03611634 -
Consitution Of A Biological Collection From Samples From The Gut Microbiote In Patients Having A Bone Or Joint Infection Treated By A Suppressive Subcutaneous Antibiotherapy With Betalactamine
|
||
Completed |
NCT03177369 -
Teicoplanin-based Antimicrobial Therapy in Staphylococcus Aureus Bone and Joint Infection: Tolerance, Efficacy and Experience With Subcutaneous Administration
|
N/A | |
Recruiting |
NCT04722926 -
Lyon PJI Retrospective Cohort Study
|
||
Completed |
NCT03852784 -
Osteoarticular Infections With Pneumococcal
|
||
Recruiting |
NCT03796104 -
Prognostic Impact of Delta-haemolysin Production Deficiency in Staphylococcus Aureus on the Prognosis of Infected Implant Treated by DAIR
|
||
Completed |
NCT03848104 -
Evaluation of the Use of Cefoxitin in Combination in Continuous Parenteral Administration in the Treatment of Bone and Joint Infections
|